The UK authorization is based on positive results from the Phase III OASIS-1, -2, and -3 trials
It is intended for contrast enhancement in MRI scans
SUP will obtain regulatory approvals for selling Tiotropium DPI in China
Shilpa Pharma Lifesciences, Unit-1, received EIR from USFDA
The closing of the Block Acquisition is now expected to be completed by Q3 2025
This study enrolled a total of 204 healthy volunteers into three groups to compare BP16 with the reference products, Prolia, obtained from both the EU and US markets
Dupixent (dupilumab) approved as the first-ever biologic medicine in Japan for patients with Chronic Obstructive Pulmonary Disease (COPD)
Adults taking Mounjaro with diet and exercise in a controlled clinical trial lost on average 21.8 kg at the highest dose (15mg) and 15.4 kg at the lowest dose (5mg)
Alkem Medtech to acquire 100% stake of Bombay Ortho
USFDA inspection at Emcure Pharmaceuticals API facility
Subscribe To Our Newsletter & Stay Updated
